Category Archives: Metastatic Prostate Cancer Disease

New Treatments For Castration Resistant Prostate Cancer

For the Ask Dr Barken Call In Show on Tuesday, April 3rd at 6pm Pacific Time:  Dial 1-877-727-3301 to hear the program. Question of the week:    For castration resistant prostate cancer, is it better to do Provenge first or … Continue reading

Posted in Castration Resistant Prostate Cancer, Immune Therapy, Metastatic Disease, Metastatic Prostate Cancer Disease, Treatments for Prostate Cancer | Tagged , , , | Leave a comment

Radium-223 ( Alpharadin): A novel Radiopharmaceutical that Prolongs Survival in Bone Metastatic Disease

  The following question is for the Ask Dr Barken Call In Show on Tuesday, March 13th at 6pm Pacific Time.  Dial 1-877-727-3301 to hear the program. Where can I get Alpharadin? What criteria will I need to meet to get … Continue reading

Posted in Ask Dr. Barken, Bone Metastases, Castration Resistant Prostate Cancer, Metastatic Disease, Metastatic Prostate Cancer Disease, Prostate Cancer, Radiation treatment, Survival prostate cancer, Treatments for Prostate Cancer | Tagged , | Leave a comment

Stromal Targeted Therapy in Bone Metastatic Disease

The following question is for the Ask Dr Barken Call In Show on Tuesday, March 6th at 6pm Pacific Time.  Dial 1-877-727-3301 to hear the program. Question of the week:    When should I start treating my bone metastatic disease?   … Continue reading

Posted in Bone Metastases, Castration Resistant Prostate Cancer, Hormone Refractory Disease, Metastatic Disease, Metastatic Prostate Cancer Disease, Treatments for Prostate Cancer | Tagged , , , | Leave a comment

Castration Resistant Prostate Cancer- Immunotherapy or Chemotherapy?

Chemotherapy or Immunotherapy for Advanced Castration Resistant Prostate Cancer Question of the week:     Should I start chemotherapy or immunotherapy for advanced castration resistant prostate cancer?     Dr. Barken will answer the question and present a related response by … Continue reading

Posted in Ask Dr. Barken, Castration Resistant Prostate Cancer, Coaching, Immune Therapy, Metastatic Disease, Metastatic Prostate Cancer Disease, Prostate Cancer, Treatments for Prostate Cancer | Leave a comment

IV Stillbestrol for advanced prostate cancer

Question Of The Week: Can you discuss Stilbestrol infusions as a treatment for castration resistant prostate cancer? For the Ask Dr Barken Call In Show on Tuesday, July 3rd at 6pm Pacific Time:  Dial 1-877-727-3301 to hear the program. The … Continue reading

Posted in Metastatic Disease, Metastatic Prostate Cancer Disease, Treatments for Prostate Cancer | Tagged , , , , | Leave a comment

New Drugs in the Pipeline for Prostate Cancer

The following question is for the Ask Dr Barken Call In Show on Tuesday, Jan. 17th at 6pm Pacific Time.  Dial 1-877-727-3301 to hear the program. Question of the week:   What is the difference between hormone-insensitive, hormone-refractory, hormone-independent and castration-resistant … Continue reading

Posted in Immune Therapy, Metastatic Disease, Metastatic Prostate Cancer Disease, Prostate Cancer, Testosterone, Treatments for Prostate Cancer | Leave a comment

Alpharadin- Experimental Treatment of Prostate Cancer Metastatic Disease in the Bones

Results of a Phase III trial with Alpharadin (radium 223-chloride) were presented at the European Cancer Organization and Congress of the European Society for Medical Oncology (ECCO-ESMO) conference in Stockholm this year.  Treatment with Alpharadin was associated with a 30% reduction … Continue reading

Posted in Metastatic Disease, Metastatic Prostate Cancer Disease, Radiation treatment, Treatments for Prostate Cancer | Tagged | 2 Comments

Multi Parametric MRI- Combidex and Ferumoxytol with Dr. J. Barentsz

Question: Although my bone scan and CT scan are negative, my PSA is rising after surgery.  What tests can I do to find out if I have prostate cancer in the lymph nodes? 1.  Dr. Barken will discuss strategies to … Continue reading

Posted in Active Surveillance, Diagnosis, Ferumoxytol, Imaging, Metastatic Disease, Metastatic Prostate Cancer Disease, MRI | Tagged , , | Leave a comment

New drug in the pipeline called Cabozantinib (XL184)

XL184 is a new drug that is being developed to treat metastatic prostate cancer in the bone. XL184 works by blocking the “angiogenesis,” or the growth of new blood vessels, to the tumor. Dr. Barken reviews briefly information from the … Continue reading

Posted in Hormone Refractory Disease, Journal Club, Metastatic Disease, Metastatic Prostate Cancer Disease, Treatments for Prostate Cancer | Tagged , | Leave a comment